The stock of Jaguar Health Inc (JAGX) has seen a 14.72% increase in the past week, with a 146.91% gain in the past month, and a 59.86% flourish in the past quarter. The volatility ratio for the week is 17.87%, and the volatility levels for the past 30 days are at 23.41% for JAGX. The simple moving average for the last 20 days is 47.18% for JAGX stock, with a simple moving average of -30.49% for the last 200 days.
Is It Worth Investing in Jaguar Health Inc (NASDAQ: JAGX) Right Now?
The 36-month beta value for JAGX is at 1.07. Analysts have varying views on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for JAGX is 262.69M, and currently, shorts hold a 5.47% of that float. The average trading volume for JAGX on April 29, 2024 was 61.31M shares.
JAGX) stock’s latest price update
Jaguar Health Inc (NASDAQ: JAGX)’s stock price has increased by 5.88 compared to its previous closing price of 0.17. However, the company has seen a 14.72% increase in its stock price over the last five trading sessions. PennyStocks reported 2024-04-23 that Penny stocks represent a unique opportunity for investors aiming to expand their portfolios without a significant initial investment. Trading penny stocks can yield high returns due to their low purchase price, making them an appealing option for both seasoned traders and newcomers to the stock market.
Analysts’ Opinion of JAGX
Many brokerage firms have already submitted their reports for JAGX stocks, with Cantor Fitzgerald repeating the rating for JAGX by listing it as a “Overweight.” The predicted price for JAGX in the upcoming period, according to Cantor Fitzgerald is $5 based on the research report published on July 07, 2021 of the previous year 2021.
Rodman & Renshaw, on the other hand, stated in their research note that they expect to see JAGX reach a price target of $2. The rating they have provided for JAGX stocks is “Buy” according to the report published on July 11th, 2017.
JAGX Trading at 90.41% from the 50-Day Moving Average
After a stumble in the market that brought JAGX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -85.25% of loss for the given period.
Volatility was left at 23.41%, however, over the last 30 days, the volatility rate increased by 17.87%, as shares surge +100.22% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +121.95% upper at present.
During the last 5 trading sessions, JAGX rose by +14.72%, which changed the moving average for the period of 200-days by -65.30% in comparison to the 20-day moving average, which settled at $0.1268. In addition, Jaguar Health Inc saw 18.89% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for JAGX
Current profitability levels for the company are sitting at:
- -3.48 for the present operating margin
- 0.73 for the gross margin
The net margin for Jaguar Health Inc stands at -4.23. The total capital return value is set at -0.92. Equity return is now at value -1919.14, with -84.10 for asset returns.
Based on Jaguar Health Inc (JAGX), the company’s capital structure generated 0.88 points at debt to capital in total, while cash flow to debt ratio is standing at -0.92. The debt to equity ratio resting at 7.3. The interest coverage ratio of the stock is -5.31.
Currently, EBITDA for the company is -31.53 million with net debt to EBITDA at -0.97. When we switch over and look at the enterprise to sales, we see a ratio of 8.23. The receivables turnover for the company is 4.47for trailing twelve months and the total asset turnover is 0.19. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.00.
Conclusion
In conclusion, Jaguar Health Inc (JAGX) has had a better performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
